Narrow search
Showing 1 - 10 of 31,467
Cover Image
A model-based perspective on health economic aspects of osteoporotic fractures
Bleibler, Florian - 2015
Persistent link: https://www.econbiz.de/10011391125
Cover Image
Orphan drugs policies : a suitable case for treatment ; editorial
Drummond, Michael F.; Towse, Adrian - In: The European journal of health economics : HEPAC ; … 15 (2014) 4, pp. 335-340
Persistent link: https://www.econbiz.de/10010360871
Cover Image
Survey of pharmacoeconomic assessment activity in eleven countries
Dickson, Michael (contributor); Hurst, Jeremy (contributor);  … - 2003 - [Elektronische Ressource]
Persistent link: https://www.econbiz.de/10002049750
Cover Image
Costs and benefits of branded drugs : insights from cost-effectiveness research
Frech, Henry Edward; Pauly, Mark V.; Comanor, William S.; … - In: Journal of benefit-cost analysis : JBCA 13 (2022) 2, pp. 166-181
The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper … branded pharmaceuticals with both higher costs and increased effectiveness compared to the previous standard of care … the variation in the cost of pharmaceuticals is, therefore, not random but rather associated with variation in QALYs …
Persistent link: https://www.econbiz.de/10013366987
Cover Image
The science of making better decisions about health : cost-effectiveness and cost-benefit analysis
Russell, Louise - 2014
Despite spending far more on medical care, Americans live shorter lives than the citizens of other high-income countries. The situation has been getting worse for at least three decades. This paper describes the main scientific methods for guiding the allocation of resources to health -...
Persistent link: https://www.econbiz.de/10010361480
Cover Image
Cost effectiveness and payment policy
Garber, Alan M.; Sculpher, Mark - 2012
Persistent link: https://www.econbiz.de/10011498356
Cover Image
Chapter Eight. Cost Effectiveness and Payment Policy
Garber, Alan M.; Sculpher, Mark J. - In: Handbook of health economics : volume 2, (pp. 471-497). 2011
Cost-effectiveness analysis is versatile and used widely to assist in health care decision making. This chapter discusses how cost-effectiveness analysis is used at the system or national level, particularly in the domain of coverage and payment policy. We describe its relationship to other...
Persistent link: https://www.econbiz.de/10014025580
Cover Image
Costs of hospital care for strokes in India : a scoping review
Benedetto, Valerio; Cadilhac, Dominique A.; Spencer, Joseph - In: The Indian economic journal 71 (2023) 5, pp. 864-877
Persistent link: https://www.econbiz.de/10014425578
Cover Image
Are biopharmaceutical budget caps good public policy?
Goldman, Dana P.; Lakdawalla, Darius; Baumgardner, James R. - In: The Economists' voice 13 (2016) 1, pp. 27-42
Persistent link: https://www.econbiz.de/10011585711
Cover Image
Cost-effectiveness and estimated health benefits of treating patients with vitamin D in pre-dialysis
Snyder, Sophie; Hollenbeak, Christopher S.; … - In: Forum for health economics & policy : an evolving … 23 (2020) 1, pp. 1-15
Persistent link: https://www.econbiz.de/10012299513